ClinicalTrials.gg
Status unknownNCT03472144Updated Mar 21, 2018

Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis

A Phase 3 interventional study of gel loaded with steroids (momentasone) and gel loaded with antibiotic (Levofloxacin) in Chronic Sinusitis, Ethmoidal, Chronic Sinusitis - Ethmoidal Anterior and Chronic Sinusitis, sponsored by LifeBridge Health. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-03-21.

Sponsored by LifeBridge Health · Phase 3, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jul 2017, registered Dec 2017).
Phase
Phase 3
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

To assess the efficacy of intra-sinus installation of a poloxamer gel that releases antibiotics and corticosteroids topically after balloon sinuplasty in chronic sinusitis patients with or without polyps. This is a single-blinded Randomized Control Trial study, in which every patient receives active gel on one side and placebo on the other (L or R to be randomly selected).

Read the detailed description

STUDY DESIGN This is a single-blinded Randomized Control Trial study, in which every patient receives active gel on one side and placebo on the other (L or R to be randomly selected). Sixty patients will be included in this study. These are patients undergoing balloon sinuplasty for Chronic sinusitis with and without polyps.

As the patients will enter the study- they will be divided into Chronic sinusitis with Polyps (CRSwNP) and Chronic rhinosinusitis without polyps (CRSsNP). Each patient will be assigned in chronological order as they will join the study.

For each group, all even numbered patients will receive the active gel application on right side and all odd number patients will receive the active gel on left side.

Then patient selection for CRSwNP and CRSsNP will be as such Each group will have 3 subgroups. Subgroup 1- gel will be loaded with steroids only Subgroup 2- gel will be loaded with antibiotic (Levaquin) only Subgroup 3- gel will be loaded with both steroids and antibiotic CRSwNP group with right side gel application Subgroup 1- patient number- 1,7,13,19,25 Subgroup 2- patient number- 3,9,15,21,27 Subgroup 3- patient number- 5,11,17,23,29 CRSwNP group with left side gel application Subgroup 1- patient number- 2,8,14,20,26 Subgroup 2- patient number- 4,10,16,22,28 Subgroup 3- patient number- 6,12,18,24,30

A similar patient randomization will be done with the CRSsNP group

Surgery will consist of plain balloon sinuplasty or hybrid balloon sinuplasty with removal of ethmoids polypss using a Blakesley forceps. During surgery, and immediately after removal of diseased mucosa, 5 ccs of an active poloxamer gel containing the antibiotic or corticosteroids or both will be instilled inside the ethmoid/ maxillary sinus/frontal cavities on one side using either the balloon catheter or as a curved suction tip. The same procedure is performed in the other side, this time with instillation of plain gel without antibiotic or corticosteroids (placebo).

The purpose of the study is to assess the efficacy of intra-sinus installation of a poloxamer gel that releases antibiotics and corticosteroids topically after balloon sinuplasty in chronic sinusitis patients with or without polyps. The assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day.

02

Conditions studied

  • Chronic Sinusitis, Ethmoidal
  • Chronic Sinusitis - Ethmoidal Anterior
  • Chronic Sinusitis
  • Chronic Sinusitis - Ethmoidal, Posterior
  • Chronic Sinusitis, Sphenoidal
  • Chronic Sinusitis - Frontoethmoidal
  • Nasal Polyps
  • Nasal Polyp - Posterior

Browse trials for

03

In context

Nasal Polyps

236 studies on the registry are indexed under Nasal Polyps; 68 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 181 interventional studies indexed under Nasal Polyps.

Browse Nasal Polyps studies →

Lead sponsor

LifeBridge Health is the lead sponsor of 31 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Chronic sinusitis symptoms with or without polyps
  2. Trial of at least 2 courses of oral antimicrobial treatment without significant improvement
  3. CAT scan showing evidence of bilateral symmetric chronic sinusitis with or without polypss
  4. Endoscopic confirmation of CRS

Exclusion criteria

Exclusion Criteria:

  1. Minor (Less than \<18 years of age).
  2. Pregnant and breastfeeding women.
  3. Allergy to specific antibiotics
  4. Patient currently taking oral .
  5. Patient currently taking oral antibiotics.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 3
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    CRSwNP - Subgrp 1(Momentasone - Right)

    Patients undergoing balloon sinuplasty will receive a gel loaded with steroids (Momentasone) only on right side and placebo on left side

    Drug: gel loaded with steroids (momentasone)

  • Experimental
    CRSwNP-Subgrp 2(Levofloxacin - Right)

    Patients undergoing balloon sinuplasty with receive a gel loaded with antibiotic (Levofloxacin) only on right side and placebo on left side

    Drug: gel loaded with antibiotic (Levofloxacin)

  • Experimental
    CRSwNP-Subgrp 3(Steroid/Antibotic Right)

    Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on right side and placebo on left side

    Drug: gel loaded with both steroids and antibiotic

  • Experimental
    CRSsNP - Subgrp 1 (Momentasone Right)

    Patients undergoing ballon sinuplasty will receive a gel loaded with steroids (Momentasone) only on right side and placebo on left side

    Drug: gel loaded with steroids (momentasone)

  • Experimental
    CRSsNP - Subgrp 2 (Levofloxacin Right)

    Patients undergoing balloon sinuplasty will receive a gel loaded with antibiotic (Levofloxacin) only on right side and placebo on left side

    Drug: gel loaded with antibiotic (Levofloxacin)

  • Experimental
    CRSsNP-Subgrp 3(Steroid/Antibiotic Right

    Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on right side and placebo on left side

    Drug: gel loaded with both steroids and antibiotic

  • Active comparator
    CRSwNP - Subgrp 1 (Momentasone Left)

    Patients undergoing balloon sinuplasty will receive a gel loaded with steroids (Momentasone) only on left side and placebo on right side

    Drug: gel loaded with steroids (momentasone)

  • Active comparator
    CRSwNP - Subgrp 2 (Levofloxacin Left)

    Patients undergoing balloon sinuplasty will receive a gel loaded with antibiotic (Levofloxacin) only left side and placebo on right side

    Drug: gel loaded with antibiotic (Levofloxacin)

  • Active comparator
    CRSwNP-Subgrp 3(Steroid/Antibiotic Left)

    Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on left side and placebo on right side

    Drug: gel loaded with both steroids and antibiotic

  • Active comparator
    CRSsNP - Subgrp 1 (Momentasone Left)

    Patients undergoing balloon sinuplasty will receive a gel loaded with steroids (Momentasone) only left side and placebo on right side

    Drug: gel loaded with steroids (momentasone)

  • Active comparator
    CRSsNP - Subgrp 2 (Levofloxacin Left)

    Patients undergoing balloon sinuplasty will receive a gel loaded with antibiotic (Levofloxacin) only left side and placebo on right side

    Drug: gel loaded with antibiotic (Levofloxacin)

  • Active comparator
    CRSsNP-Subgrp 3(Steroid/Antibiotic Left)

    Patients undergoing balloon sinuplasty will receive a gel loaded with both steroids and antibiotic on left side and placebo on right side

    Drug: gel loaded with both steroids and antibiotic

Interventions

  • Druggel loaded with steroids (momentasone)

    One of the purpose of this study is to evaluate the efficacy of a gel that actively releases local corticosteroids (momentasone) after balloon sinuplasty for chronic sinusitis patients.

    Also known as: Momentasone

  • Druggel loaded with antibiotic (Levofloxacin)

    Drug page: Levofloxacin

    One of the purpose of this study is to evaluate the efficacy of a gel that actively releases local antibiotic(levofloxacin) after balloon sinuplasty for chronic sinusitis patients.

    Also known as: Levofloxacin

  • Druggel loaded with both steroids and antibiotic

    One of the purpose of this study is to evaluate the efficacy of a gel that actively releases local both steroids (momentasone)and antibiotic(levofloxacin) after balloon sinuplasty for chronic sinusitis patients.

    Also known as: Momentasone, Levofloxacin

06

What researchers measure

Primary outcomes

  1. Clinical improvement reported on SNOT-22 questionnaire

    Assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day.

    Time frame: The total duration of the actual study is 30 months, and the follow up period per patient will 6 months postoperatively.

  2. Improvement in the Lund-Kennedy endoscopic appearance scores. Improvement in the Lund-Kennedy endoscopic appearance scores

    Assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day. Polyps (left, right) Edema (left, right) Discharge (left, right) Scarring (left, right) Crusting (left, right) Scoring: Polyps on left side - (0 absent, 1 polyps in middle meatus, 2 polyps beyond middle meatus) Polyps on right side - (0 absent, 1 polyps in middle meatus, 2 polyps beyond middle meatus) Edema, scarring and crusting on left side (0 absent, 1 mild, 2 severe) Edema, scarring and crusting on right side (0 absent, 1 mild, 2 severe) Discharge on left side (0, no discharge, 1 clear, thin discharge, 2 thick purulent discharge) Discharge on right side (0, no discharge, 1 clear, thin discharge, 2 thick purulent discharge)

    Time frame: The total duration of the actual study is 30 months, and the follow up period per patient will 6 months postoperatively.

Secondary outcomes

  1. Radiological improvement of the Lund-Mackay score

    Assessment of the healing process will be done at the end of one month then at two, three and six months. Total number of visits would be 8 including the operation day. Paranasal sinuses Right Left Maxillary (0, 1, 2) Anterior Ethmoid (0, 1, 2) Posterior Ethmoid (0, 1, 2) Sphenoid (0, 1, 2) Frontal (0, 1, 2) * Ostiomeatal complex (0, 2) Total Note: 0- without abnormalities; 1- partial opacification; 2-total opacification * 0-no obstruction; 2-obstructed

    Time frame: The total duration of the actual study is 30 months, and the follow up period per patient will 6 months postoperatively.

07

Study locations

1 of 1 sites recruiting
  • Sinai Hospital of Baltimore
    Baltimore, Maryland 21215, United States
    Recruiting
08

References and documents

Publications

  • Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, Ganiats TG, Gelzer A, Hamilos D, Haydon RC 3rd, Hudgins PA, Jones S, Krouse HJ, Lee LH, Mahoney MC, Marple BF, Mitchell CJ, Nathan R, Shiffman RN, Smith TL, Witsell DL. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007 Sep;137(3 Suppl):S1-31. doi: 10.1016/j.otohns.2007.06.726. PubMed 17761281 ↗
  • Vaughan WC. Review of balloon sinuplasty. Curr Opin Otolaryngol Head Neck Surg. 2008 Feb;16(1):2-9. doi: 10.1097/MOO.0b013e3282f5e955. PubMed 18197013 ↗
  • Hopkins C, Browne JP, Slack R, Lund V, Brown P. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol Head Neck Surg. 2007 Oct;137(4):555-61. doi: 10.1016/j.otohns.2007.02.004. PubMed 17903570 ↗
  • Alves DA, Machado D, Melo A, Pereira RF, Severino P, de Hollanda LM, Araujo DR, Lancellotti M. Preparation of Thermosensitive Gel for Controlled Release of Levofloxacin and Their Application in the Treatment of Multidrug-Resistant Bacteria. Biomed Res Int. 2016;2016:9702129. doi: 10.1155/2016/9702129. Epub 2016 Sep 5. PubMed 27689094 ↗
  • Li C, Gu J, Mao X, Ao H, Yang X. Preparation of levofloxacin thermo-sensitive gel and clinical application in the treatment of suppurative otitis media. Acta Otolaryngol. 2014 May;134(5):468-74. doi: 10.3109/00016489.2013.878473. Epub 2014 Mar 6. PubMed 24597493 ↗
  • Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006 Dec;23(12):2709-28. doi: 10.1007/s11095-006-9104-4. Epub 2006 Nov 11. PubMed 17096184 ↗
  • Shikani AH, Chahine KA, Alqudah MA. The rhinotopic protocol for chronic refractory rhinosinusitis: how we do it. Clin Otolaryngol. 2010 Aug;35(4):329-32. doi: 10.1111/j.1749-4486.2010.02157.x. No abstract available. PubMed 20738346 ↗
  • Shikani AH, Chahine KA, Alqudah MA. Rhinotopic therapy for refractory chronic rhinosinusitis: a study of 20 cases. Ear Nose Throat J. 2014 Apr-May;93(4-5):E48-54. PubMed 24817242 ↗
  • Shikani AH, Kourelis K, Rohayem Z, Basaraba RJ, Leid JG. Topical gel therapy for sinonasal polyposis in Samter's triad: preliminary report. Ann Otol Rhinol Laryngol. 2012 Nov;121(11):719-24. doi: 10.1177/000348941212101104. PubMed 23193904 ↗

Individual participant data

Plan to share: Undecided — undecided so far

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03472144
Lead sponsor
LifeBridge Health
Responsible party
Sponsor
First posted
Mar 21, 2018
Start date
Jul 7, 2017
Primary completion
Jul 7, 2019 (estimated)
Completion
Dec 7, 2019 (estimated)
Last update
Mar 21, 2018

Study contacts

Alan H. Shikani, MD
Contact
ashikani@gmail.com
410-601-6673
Alan H. Shikani, MD
principal investigator · Sinai Hospital of Baltimore

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Levofloxacin

Start the discussion